Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The authors clarify statements and correct misinterpretations regarding the 2013 guidelines on cardiovascular risk assessment and cholesterol treatment.
As the chairs of the 2013 guideline panels on risk assessment and cholesterol treatment,1,2 we would like to clarify some statements made in 3 Viewpoint articles3- 5 and correct some misinterpretations or incorrect assumptions.
No takes yet. Share an insight, caveat, or question.
Lloyd‐Jones et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: